Stevia Leaf Extracts Show Potential Against Pancreatic Cancer

Recent research from Hiroshima University in Japan suggests that stevia leaf extracts might have a role in treating pancreatic cancer cells. Stevia, a natural sweetener derived from the leaves of the plant Stevia rebaudiana, is often used as a sugar substitute.

Published in the International Journal of Molecular Sciences, this study explored the anticancer properties of stevia leaf extracts that were fermented with certain bacteria. The findings from laboratory experiments indicated that these fermented extracts significantly boosted antioxidant activity and showed cytotoxic effects against pancreatic cancer cells.

These results have led researchers to believe that the substance could be a promising candidate for pancreatic cancer treatment.

Dr. Paul E. Oberstein, a medical oncologist at the NYU Langone Perlmutter Cancer Center, commented on the study, emphasizing its relevance. He noted, “This is an interesting study because it evaluated what originated from a natural plant and showed its usefulness in stopping cancer cells from growing in the laboratory.” However, he pointed out that raw stevia plants do not exhibit the same anti-cancer properties, and chemical modifications were necessary for the fermentation process to enhance their effectiveness.

While optimistic, Oberstein advised caution, mentioning the uncertainty surrounding potential side effects from the modified plants. He stated that further research is needed, especially regarding human applications, saying, “There is still a lot unclear whether this will be useful to patients.”

Despite the promising nature of these findings, they have not yet translated into clinical implications. Oberstein explained that only the extracts modified in the lab have shown potential, whereas standard stevia has no effect on cancer cells.

Dr. Kristen Arnold, a surgical oncologist specializing in pancreatic cancer at the Orlando Health Cancer Institute, also expressed cautious optimism regarding the research. She underscored the aggressive nature of pancreatic cancer and the ongoing search for better treatment methods. Arnold mentioned the importance of ongoing efforts in the pancreatic cancer community to find more effective treatments.

She did convey excitement about this groundbreaking study, highlighting that it’s early to tell if this could fundamentally change treatment protocols. Still, the presence of positive preclinical data is encouraging. Arnold concluded by encouraging individuals with pancreatic cancer to seek clinical trial opportunities as new research unfolds, stating, “Clinical trials ultimately determine how patients are treated daily.”

In summary, while the findings from Hiroshima University are intriguing and suggest a potential avenue for future treatment, more rigorous testing and research are needed to ascertain the safety and effectiveness of stevia leaf extracts in clinical settings.